Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1407 of 5804
-
New diabetes drug HTD1801 put to the test in 551-Person trial
Disease control CompletedThe goal of this clinical study is to evaluate the efficacy and safety of berberine ursodeoxycholate (HTD1801) compared to placebo in patients with type 2 diabetes inadequately controlled with metformin.
Phase: PHASE3 • Sponsor: HighTide Biopharma Pty Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Green tea shows promise in preventing diabetes in obese kids
Disease control CompletedThe aim of this research is to evaluate the safety and efficacy of green tea in obese pediatrics with prediabetes versus the metformin therapy alone that is given to these patients. The primary outcome is to tackle the insulin resistance in these patients to prevent the deteriora…
Phase: PHASE3 • Sponsor: Ain Shams University • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Extended immunotherapy shows promise for tough prostate cancer
Disease control OngoingProposed immunotherapy with an extended course of Sipuleucel-T treatment may induce a more robust immune response and improve the anti-cancer efficacy of Sipuleucel-T in patients with metastatic Castration-Resistant Prostate Cancer (mCRPC).
Phase: PHASE1 • Sponsor: University of Oklahoma • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Could a jolt of electricity make immunotherapy work better for melanoma?
Knowledge-focused ENROLLING_BY_INVITATIONIn the last 10 years, the treatment of metastatic cutaneous melanoma has changed dramatically. The new systemic treatment with immunotherapy has led to a dramatic improvement in quality of life and overall survival. Systemic treatment means that the patient receives the drug as a…
Phase: NA • Sponsor: Institute of Oncology Ljubljana • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
Diabetes drug shows promise for PCOS in new study
Disease control CompletedChronic inflammation is the core of Polycystic ovary syndrome (PCOS), and obesity and overweight further exacerbate the level of inflammation in the peripheral circulation and ovarian tissue in PCOS patients. Metformin is a classic endocrine drug for the treatment of PCOS, but it…
Phase: NA • Sponsor: Shanghai 10th People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New hope for sarcoidosis patients: drug aims to tame lung inflammation and cut steroids
Disease control Recruiting nowA phase 1b/2 study of XTMAB-16 in patients with pulmonary sarcoidosis
Phase: PHASE1, PHASE2 • Sponsor: Xentria, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Stitch in time: new trial aims to stop preterm birth in High-Risk pregnancies
Disease control Recruiting nowThe goal of this clinical trial is to determine whether cervical cerclage reduces the risk of preterm birth in patients with a short transvaginal ultrasound (TVU) cervical length (CL) ≤25mm between 24 0/7-26 6/7 weeks.
Phase: NA • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New depression drug tested for long-term safety in 1,000 patients
Disease control OngoingThis is a 52-week open-label extension (OLE) study that will evaluate the safety, tolerability, and effectiveness of NMRA-335140 in participants with major depressive disorder (MDD). Participants who completed a parent study investigating the efficacy and safety of NMRA-335140 as…
Phase: PHASE3 • Sponsor: Neumora Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New drug combo aims to control rare ovarian cancer
Disease control Recruiting nowTo learn if the combination of dostarlimab and LB-100 can help to control ovarian clear cell carcinoma
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Old drug, new hope: atovaquone tested against tough ovarian cancer
Disease control Recruiting nowThis phase II trial test tests how well repurposing atovaquone works in treating patients with platinum-resistant ovarian cancer. Atovaquone is used for the treatment or prevention of certain infections. Atovaquone is in a class of medications called antiprotozoal agents. It work…
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 26, 2026 16:38 UTC
-
New antibody drug shows promise for tough eczema cases
Disease control OngoingThis is a Phase IB/IIA clinical study of BAT6026 in patients with AD. The subjects were adults with moderate to severe atopic dermatitis (AD) whose disease was not adequately controlled by prior topical medications or for which topical medications were not appropriate. The first …
Phase: PHASE1, PHASE2 • Sponsor: Bio-Thera Solutions • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
10-Week therapy aims to curb impulsive behaviors in young BPD patients
Symptom relief Recruiting nowBorderline personality disorder (BPD) is a severe, high-suicidal psychiatric disorder associated with impulsive, endangering behaviors. Young patients between 16 and 25 years old do not respond to traditional psychotherapies, which are often long and not adapted to their neurocog…
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
Virus cocktail takes on Antibiotic-Resistant foot infections
Disease control CompletedTP-102 is a novel bacteriophage cocktail comprised of 5 (five) lytic bacteriophages against Staphylococcus aureus, Pseudomonas aeruginosa, and Acinetobacter baumannii. TP-102 is being developed for topical treatment of patients with wound infections including chronic ulcers; appl…
Phase: PHASE2 • Sponsor: Technophage, SA • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Could a new pill calm brain inflammation and slow Parkinson's-Linked sleep disorder?
Disease control OngoingThis study is to investigate the safety and efficacy of PXS-4728A as an intervention therapy in participants with iRBD. This study will be conducted in participants aged 50 to 80 years of age and will investigate a single dose level.
Phase: PHASE2 • Sponsor: Syntara • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
One-shot radiation zaps liver tumors in colorectal cancer trial
Disease control Recruiting nowThe researchers are doing this study to see if one session of high-dose contrast-enhanced MRI-guided SBRT (stereotactic body radiation therapy) is effective for colorectal cancer that has spread to the liver. The researchers will evaluate how well the study treatment can prevent …
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New Antibody-Drug conjugate STRO-002 tested in advanced cancers
Disease control CompletedThis is a multi-center, open-label, monotherapy dose escalation, PK bridging, and dose expansion Phase I/IIa study in Chinese adult subjects to evaluate the safety, tolerability, Pharmacokinetics (PK) profiles, immunogenicity, and preliminary efficacy of STRO-002 in patients with…
Phase: PHASE1, PHASE2 • Sponsor: Tasly Pharmaceutical Group Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Pen and paper therapy: new study aims to stop PTSD after traumatic birth
Prevention Recruiting nowThe goal of this clinical trial is to test a brief psychological intervention given to individuals in the first days following childbirth who have experienced a potentially stressful childbirth. The treatment is aimed at preventing post-traumatic stress disorder following childbi…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Prevention
Last updated Jun 27, 2026 12:37 UTC
-
Simple saltwater solution may shield kidneys after heart transplant
Prevention Recruiting nowThe goal of this study is to evaluate if hypertonic saline solution can prevent or attenuate acute kidney injury after heart transplantation in the early postoperative phase.
Phase: PHASE2 • Sponsor: Fernando Bacal • Aim: Prevention
Last updated Jun 27, 2026 12:29 UTC
-
New cancer drug MBRC-101 enters human trials for Hard-to-Treat tumors
Disease control Recruiting nowThis is a first-in-human (FIH), open label Phase 1/1b / Phase 2 study in patients with advanced metastatic solid tumors refractory to standard treatment. Phase 1 will identify potential optimal biologically relevant doses (OBRD) and the maximum tolerated dose (MTD) of MBRC-101 at…
Phase: PHASE1, PHASE2 • Sponsor: MBrace Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Kidney transplant trial tests which drug better prevents rejection
Disease control Recruiting nowInduction therapy decreases the rate of acute allograft rejection in kidney transplant recipients (KTRs) and is strongly recommended. Polyclonal lymphocyte-depleting antibodies and interleukin-2 receptor (IL2R) antagonists are therefore widely used around the world, with a leadin…
Phase: PHASE3 • Sponsor: University Hospital, Tours • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC